{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Charles City",
      "state": "IA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "76166",
      "recalling_firm": "Cambrex Charles City Inc",
      "address_1": "1205 11th St",
      "address_2": "N/A",
      "postal_code": "50616-3466",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "N/A",
      "distribution_pattern": "Product distributed solely to the state of Minnesota.",
      "recall_number": "D-0447-2017",
      "product_description": "Mesalamine, U.S.P. [CAS 89-57-6] Cambrex Charles City, Inc. Charles City, IA packaged in double lined PE liners inside Poly-lined cardboard drums. Net weight 40 kg",
      "product_quantity": "2351.12 pound container",
      "reason_for_recall": "Presence of Particulate Matter: Stainless steel in a chemical reactor dissolved into the API solution and was detected in the finished product.",
      "recall_initiation_date": "20140520",
      "center_classification_date": "20170126",
      "termination_date": "20170309",
      "report_date": "20170201",
      "code_info": "Code 1661911; Batch 1340;  Exp. 03/17"
    }
  ]
}